SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-23-016703
Filing Date
2023-12-21
Accepted
2023-12-21 16:30:16
Documents
9
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 b12212306k.htm 6-K 32904
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 252553
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 120199
4 EXHIBIT 4.2 ex4_2.htm EX-4.2 112778
5 EXHIBIT 4.3 ex4_3.htm EX-4.3 120241
6 EXHIBIT 4.4 ex4_4.htm EX-4.4 120595
7 EXHIBIT 4.5 ex4_5.htm EX-4.5 20565
8 EXHIBIT 99.1 ex99_1.htm EX-99.1 14217
9 EXHIBIT 99.2 ex99_2.htm EX-99.2 18581
  Complete submission text file 0001214659-23-016703.txt   813804
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 231505702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)